BioTime Announces Additional Products in Development Based on HyStem® Technology

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX), today announced that it has initiated the development of two new products based on its HyStem® hydrogel technology platform.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC